A Study Comparing BGB-3111 and Ibrutinib in Participants With Waldenström's Macroglobulinemia (WM)

Clinical trial NCT03053440 · COMPLETED

Trial details

NCT number: NCT03053440
Sponsor: BeiGene
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Waldenström's Macroglobulinemia

Start date: 2017-01-25
Primary completion: 2022-06-21
Enrollment: 201

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.